Petros Pharmaceuticals, Inc.
PTPI
$0.01
$0.001.41%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 113.36% | -48.57% | -17.93% | -61.24% | -75.41% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -166.64% | 162.09% | 203.47% | 533.16% | 442.02% |
| Change in Net Operating Assets | -148.91% | -87.12% | 170.53% | -141.41% | -142.66% |
| Cash from Operations | -158.73% | 17.03% | 50.86% | 60.96% | 65.87% |
| Capital Expenditure | -- | 200.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 71.73% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -41.95% | -41.95% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 94.52% | 79.03% | 20.01% | -63.85% | -211.88% |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -1.50% | -- | -- |
| Cash from Financing | 216.60% | 185.28% | -52.51% | -73.74% | -160.67% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.82% | 115.46% | -284.18% | -111.73% | -346.17% |